CURRENT PROJECTS
ARGYRIN
In an exemplary TRAIN co-operation project Nisar Malek of the MHH, Ronald Frank of HZI and Markus Kalesse from LUH are working together to develop a new active agent candidate to counteract cancer, Argyrin.
This natural substance is currently being chemically optimised and developed for clinical investigation by the translation alliance partners.
Download PDF
Information about the ARGYRIN project
An HZI press release about ARGYRIN can be found here.
A podcast of the Helmholtz Association on the subject of ARGYRIN can be found here.
THUGGACIN
In the scope of TRAIN chemist Andreas Kirschning (LUH) is co-operating closely with the HZI natural substance researcher Rolf Jansen and MHH clinical researcher Franz Bange on the development of Thuggacin into an antibiotic to counter tuberculosis.
